Korro Bio, Inc. (KRRO) Stock Ticker
KRRO right now
Market factors today
Unlock the full KRRO picture
About Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
KRRO stock facts
| Ticker symbol | KRRO |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $95.3M |
| CEO | Ram Aiyar |
| Employees | 57 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2019-10-03 |
| Website | www.korrobio.com |
What you can see for KRRO on Tickr
Live KRRO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KRRO report.
Rankings
FAQ
What is the ticker symbol for Korro Bio, Inc.?
The ticker symbol for Korro Bio, Inc. is KRRO, listed on the NASDAQ Capital Market.
What is KRRO?
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.